BioIVT, a leading provider of biospecimens, research models, and services for drug and diagnostic development, today announced its scientific contributions to the 2023 Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo. This year’s conference will be held from March 19-23 at the Nashville Music City Center in Nashville, TN.
“We look forward to catching up with our research colleagues at the SOT Annual Meeting and discussing recent scientific advances,” said Dr. Christopher Black, BioIVT Senior Vice President, ADME-Tox. “Our goal at BioIVT is to be the trusted partner for in vitro…
CN Bio appoints Deepak Singh as Vice President of Sales and Marketing
Key appointment as company seeks to continue global expansion of microphysiological systems and contract research service offerings
Cambridge, UK, 14 March 2023: CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has today announced that is has appointed Deepak Singh as Vice President of Sales and Marketing. Deepak’s appointment supports the Company’s next phase of commercial development as it expands international operations, product…
Leading Scientists Discuss 3D Organoid Culture Research
AMSBIO has interviewed two extraordinary women in the 3D Cell Culture and Organoid field; Dr Hynda Kleinman, one of the co-inventors of Matrigel, and Dr Meritxell Huch, a director at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) to mark International Women’s Day on the 8th March, and World Organoid Research Day on 22nd March 2023.
Topics covered in this informative interview include: how they got into 3D organoid culture research; their experiences in the field and how the field has changed; challenges they…
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced three senior appointments to its newly incorporated subsidiary company, Inaphaea BioLabs (Inaphaea).
Headquartered in MediCity Nottingham, Inaphaea will offer a wide range of pre-clinical and drug discovery testing services to academic, biotech and pharmaceutical researchers, forming the foundation of ValiRx’s tCRO™ (translational Contract Research Organisation) strategy.
As a wholly owned subsidiary of ValiRx, Inaphaea will have the capability to conduct in vitro and ex vivo…
AMSBIO has published an interview with Professor Ryuji Morizane, a renowned expert in renal research at Harvard Medical School. In his award-winning research*, Professor Morizane has successfully combined organoid and bioengineering technology to create kidney organoids that incorporate a vascular structure.
To help facilitate this pioneering work, Professor Morizane research group uses StemFit® - a feeder-free, chemically defined culture medium for embryonic (ES) and induced pluripotent stem cells (iPSC) which are without human or animal-derived components…
CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System
PhysioMimix HT System increases productivity, cost-effectiveness and data robustness
Developed to enable earlier adoption of predictive human liver Organ-on-a-Chip models in drug discovery workflows
New PhysioMimix multi-chip consumable plate containing 48 liver chips also launched
Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the commercial…
Check out your monthly round up of employee engagement opportunities in this month's People Pathways newsletter!
ICRISAT and Eagle Genomics sign Memorandum of Understanding
Internationally renowned science-based organisation and pioneering TechBio platform expected to deliver innovative nature-based solutions through exciting public-private relationship
Networking microbiome science to tackle the world’s Grand Challenges including effects of climate change
Hyderabad, India: A new cooperation framework was signed today between the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) and Eagle Genomics at the International Conference on Innovations to Transform Drylands. …
NRG Therapeutics Awarded Second $500K Grant from The Michael J. Fox Foundation to Further Progress Parkinson’s Programme
Stevenage, UK, 22 February 2023 - NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has been awarded a second $500,000 grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to support its lead drug discovery programme and the development of a novel treatment for Parkinson’s.
NRG Therapeutics is applying breakthrough science in the field of mitochondrial biology to develop first…